PwC with TVM on the Series C round of Smart Reporting
A multidisciplinary team from PwC Legal and the auditing and consulting firm PwC Germany provided legal and tax advice to the venture capital company TVM Capital Life Science as lead investor in the Series C financing round of Smart Reporting.
Smart Reporting, headquartered in Munich, is a pioneer and market leader in the field of medical reporting, particularly in the areas of radiology and pathology. The vendor-independent software “SmartReports” offers a fully voice-controlled and data-driven docu-mentation solution for doctors, which forms the basis for workflow automation and machine-readable data. The software is distributed internationally via major healthcare IT partner-ships. With the additional funds from the Series C financing round, Smart Reporting intends to continue its international growth strategy, which was recently launched with its market entry in the USA. The focus will lie on penetrating key global healthcare IT markets and the productization of AI-based solutions.
TVM Capital Life Science (TVM) is a leading international venture capital investment compa-ny that invests in innovations in the life science sector. TVM manages a total of around 900 million US dollars via several funds. TVM’s portfolio focuses on therapeutics and medical technologies from Europe and North America, in particular first-in-class or best-in-class as-sets that have the potential to transform standard care for patients.
Advisor to TVM Capital Life Science:
PwC Legal:
Dr. Jörg Ritter (lead, pictured), Christine Kaniak-Hockel, Dr. Thomas Wenninger, Alexander Schmidt, Markus Breitenbücher (all corporate/M&A), Dr. Frank Degenhardt, Boris Christian, Markus Gortan (all labor law), Janina Thieme, Dinor Kadrijaj (both IP/IT)
PwC Germany:
Daniel Keller, Lukas Grüttner, Christoph Steuer (all Tax)
For the US aspects of the transaction, PwC Legal brought in a team led by J.T. Ho and Sarah Schaedler from the San Francisco office of the law firm Orrick, Herrington & Sutcliffe.
